Which has the lower trailing P/E, MEDP or RVTY?

MEDP has the lower trailing P/E: MEDP trades at 33.81 and RVTY at 53.58. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, MEDP or RVTY?

Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus RVTY at -8.12%.

Does MEDP or RVTY pay a bigger dividend?

RVTY pays a dividend (0.25% yield), while MEDP has no payments in the available dividend history.

Is MEDP or RVTY more profitable?

MEDP runs the higher net margin — MEDP at 17.67% versus RVTY at 8.30%.

How have MEDP and RVTY total returns compared?

Over the past 5 years, MEDP delivered 26.81% and RVTY delivered 7.36% annualized total return. Past performance doesn't predict future results.

Medpace Holdings, Inc. (MEDP) vs Revvity, Inc. (RVTY)

A side-by-side comparison of Medpace Holdings, Inc. and Revvity, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.

MEDP

Medpace Holdings, Inc.

$16.11B

$577.11HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

RVTY

Revvity, Inc.

$12.55B

$112.52HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

Total return — MEDP vs RVTY

growth of $100 · dividends reinvested · last 10y

MEDP +1976.7%RVTY +111.1%MEDP compounded faster

Log scale — wide-divergence pair

MEDP RVTY

MEDP vs RVTY: by the numbers

•MEDP is the larger company ($16.11B vs $12.55B market cap).
•MEDP trades at the lower trailing earnings multiple (33.81 vs 53.58 P/E), one valuation lens rather than an overall verdict.
•MEDP converts more revenue to profit (17.67% vs 8.30% net margin).
•MEDP grew revenue faster over the past five years (22.03% vs -8.12% CAGR).
•RVTY pays a dividend (0.25% yield), while MEDP has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	MEDP	RVTY
P/E ratio	33.81	53.58
Forward P/E	32.79	21.47
P/S ratio	5.97	4.34
P/B ratio	38.26	1.75
PEG ratio	1.82	N/A
EV / EBITDA	27.14	19.50
FCF yield	4.42%	3.92%

Profitability

Metric	MEDP	RVTY
Gross margin	28.76%	51.44%
Operating margin	20.97%	12.41%
Net margin	17.67%	8.30%
ROE	113.29%	3.35%
ROIC	67.94%	2.82%

Dividends

Metric	MEDP	RVTY
Dividend yield	N/A	0.25%
Payout ratio	N/A	13.46%

Growth (annualized)

Metric	MEDP	RVTY
Revenue CAGR (5Y)	22.03%	-8.12%
EPS CAGR (5Y)	30.90%	-20.48%
FCF CAGR (5Y)	23.40%	-16.70%
Total return CAGR (5Y)	26.81%	-8.97%

Frequently asked

Which has the lower trailing P/E, MEDP or RVTY?: MEDP has the lower trailing P/E: MEDP trades at 33.81 and RVTY at 53.58. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, MEDP or RVTY?: Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus RVTY at -8.12%.
Does MEDP or RVTY pay a bigger dividend?: RVTY pays a dividend (0.25% yield), while MEDP has no payments in the available dividend history.
Is MEDP or RVTY more profitable?: MEDP runs the higher net margin — MEDP at 17.67% versus RVTY at 8.30%.
How have MEDP and RVTY total returns compared?: Over the past 5 years, MEDP delivered 26.81% and RVTY delivered 7.36% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MEDP analysis Full RVTY analysis Interactive comparison tool

Dig into the metrics

Medpace P/E ratio Revvity P/E ratio Medpace dividend yield Revvity dividend yield Medpace ROE Revvity ROE Medpace operating margin Revvity operating margin Medpace revenue growth Revvity revenue growth Medpace free cash flow Revvity free cash flow

Medpace & Revvity appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.